Impact of lung metastases on overall survival in the phase 3 SELECT study of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer

Lung metastases may worsen overall survival (OS) in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). We investigated (post hoc) the impact of lung metastases on survival in SELECT (a phase 3 study).

Source: European Journal of Cancer - February 19, 2021 Category: Cancer & Oncology Authors: Makoto Tahara, Naomi Kiyota, Ana O. Hoff, Corin Badiu, Taofeek K. Owonikoko, Corina E. Dutcus, Takuya Suzuki, Min Ren, Lori J. Wirth Tags: Original Research Source Type: research